Literature DB >> 6752186

Fluorescent-antibody test for detection of Clostridium difficile in stool specimens.

K H Wilson, J Silva, F R Fekety.   

Abstract

We evaluated a direct fluorescent-antibody test to detect Clostridium difficile, the most frequent cause of antibiotic-associated colitis. C. difficile organisms were injected into the ear veins of New Zealand White rabbits to induce antibodies, and the globulin fractions of their sera were conjugated to fluorescein isothiocyanate. The resulting conjugate strongly stained all 40 isolates of C. difficile tested. It also stained isolates of C. sordellii, C. bifermentans, C. chauvoei, and C. sporogenes, but not 20 other clostridial isolates or 10 isolates from other species. Results of testing fecal smears with the direct fluorescent-antibody method were compared with results of testing stools for C. difficile toxin and of culturing for C. difficile on a selective medium. A total of 158 fecal specimens from patients with antibiotic-associated diarrhea were tested. In these patients, the fluorescent-antibody test agreed with culture and toxin testing in 93% of the specimens. However, in normal adults, 62% of the fecal specimens from which C. difficile could not be cultured were positive by the fluorescent-antibody test. Absorption of the conjugate with C. sordellii led to a loss of reactivity to other clostridia as well as to 18 of 20 isolates of C. difficile.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752186      PMCID: PMC272390          DOI: 10.1128/jcm.16.3.464-468.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Rapid detection of Clostridium difficile toxin in human feces.

Authors:  R W Ryan; I Kwasnik; R C Tilton
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

2.  Enzyme immunoassay for the detection of Clostridium difficile antigen.

Authors:  R H Yolken; L S Whitcomb; G Marien; J D Bartlett; J Libby; M Ehrich; T Wilkins
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

3.  Detection of Clostridium difficile toxin by counterimmunoelectrophoresis: a note of caution.

Authors:  I R Poxton; M D Byrne
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

4.  Antibiotic-associated colitis--a review of 66 cases.

Authors:  G A Mogg; M R Keighley; D W Burdon; J Alexander-Williams; D Youngs; M Johnson; S Bentley; R H George
Journal:  Br J Surg       Date:  1979-10       Impact factor: 6.939

5.  Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin.

Authors:  S E West; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

6.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

7.  Immunological analysis of the EDTA-soluble antigens of Clostridium difficile and related species.

Authors:  I R Poxton; M D Byrne
Journal:  J Gen Microbiol       Date:  1981-01

8.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

9.  Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis.

Authors:  D F Welch; S K Menge; J M Matsen
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

10.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

  10 in total
  8 in total

1.  Evaluation of gas-liquid chromatography for the rapid diagnosis of Clostridium difficile associated disease.

Authors:  P Gianfrilli; A Pantosti; I Luzzi
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

2.  Use of gas-liquid chromatography as a screening test for toxigenic Clostridium difficile in diarrhoeal stools.

Authors:  F Pepersack; M Labbe; C Nonhoff; E Schoutens
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

Review 3.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

4.  Detection of Clostridium difficile in faeces by direct gas liquid chromatography.

Authors:  P N Levett
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

5.  Enzyme immunoassay for detection of Clostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

Review 6.  Laboratory diagnosis of Clostridium difficile-associated diarrhoea.

Authors:  R A Bowman; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

7.  Latex agglutination test for detection of Clostridium difficile toxin in stool samples.

Authors:  M S Shahrabadi; L E Bryan; D Gaffney; S E Coderre; R Gordon; C H Pai
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

8.  Identification of RNAs bound by Hfq reveals widespread RNA partners and a sporulation regulator in the human pathogen Clostridioides difficile.

Authors:  Pierre Boudry; Emma Piattelli; Emilie Drouineau; Johann Peltier; Anaïs Boutserin; Maxence Lejars; Eliane Hajnsdorf; Marc Monot; Bruno Dupuy; Isabelle Martin-Verstraete; Daniel Gautheret; Claire Toffano-Nioche; Olga Soutourina
Journal:  RNA Biol       Date:  2021-02-25       Impact factor: 4.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.